Cargando…
Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887006/ https://www.ncbi.nlm.nih.gov/pubmed/34910598 http://dx.doi.org/10.1164/rccm.202111-2593ED |
| _version_ | 1784660805286887424 |
|---|---|
| author | Zampieri, Fernando G. Ginde, Adit |
| author_facet | Zampieri, Fernando G. Ginde, Adit |
| author_sort | Zampieri, Fernando G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8887006 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88870062022-03-02 Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients Zampieri, Fernando G. Ginde, Adit Am J Respir Crit Care Med Editorials American Thoracic Society 2021-12-15 /pmc/articles/PMC8887006/ /pubmed/34910598 http://dx.doi.org/10.1164/rccm.202111-2593ED Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org). |
| spellingShingle | Editorials Zampieri, Fernando G. Ginde, Adit Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients |
| title | Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients |
| title_full | Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients |
| title_fullStr | Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients |
| title_full_unstemmed | Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients |
| title_short | Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients |
| title_sort | making sense of phase ii trials for investigational agents in covid-19: the case of ilomedin in mechanically ventilated patients |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887006/ https://www.ncbi.nlm.nih.gov/pubmed/34910598 http://dx.doi.org/10.1164/rccm.202111-2593ED |
| work_keys_str_mv | AT zampierifernandog makingsenseofphaseiitrialsforinvestigationalagentsincovid19thecaseofilomedininmechanicallyventilatedpatients AT gindeadit makingsenseofphaseiitrialsforinvestigationalagentsincovid19thecaseofilomedininmechanicallyventilatedpatients |